The 31 references in paper A. Chernov N., А. Чернов Н. (2017) “COОТНОШЕНИЕ РЕЦЕПТОРОВ TrkA И р75 НА КЛЕТКАХ НЕЙРОЭПИТЕЛИАЛЬНЫХ ОПУХОЛЕЙ – НОВАЯ МИШЕНЬ ВОЗДЕЙСТВИЯ КОМБИНАЦИЙ ФАКТОРА РОСТА НЕРВОВ С ЦИСПЛАТИНОМ ИЛИ ТЕМОЗОЛОМИДОМ // THE RATIO OF TrkA AND p75 RECEPTORS ON THE CELL NEUROEPITHELIAL TUMORS – A NEW TARGET EFFECT OF NERVE GROWTH FACTOR WITH CISPLATIN AND TEMOZOLOMIDE AND THE COMBINATIONS” / spz:neicon:ogsh:y:2016:i:4:p:53-61

1
Grauer O., Pascher Ch., Hartmann Ch. et al. Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). J Neurooncol 2011;104(3):801–9.
(check this in PDF content)
2
Савва Н.Н., Зборовская А.А., Алейникова О.В. Злокачественные новообразования у детей Беларуси: заболеваемость, выживаемость, смертность, подходы к паллиативной помощи. Минск, 2008. 180 с. [Savva N.N., Zborovskaya A.A., Aleynikova O.V. Malignant tumors in children of Belarus: incidence, survival, mortality approaches to palliative care. Minsk, 2008. 180 p. (In Russ.)].
(check this in PDF content)
3
Lafai-Cousin L., Strother D. Current treatment approaches for infants with malignant central nervous system tumors. Oncologist 2009;14:433–44.
(check this in PDF content)
4
Конопля Н.Е. Лечение медуллобластомы у детей младше 4 лет. Meдицинский журнал 2009;(1):112–4. [Коnоplya N.Е. Treatment of medulloblastoma in children younger than 4 years. Meditsinskiy zhurnal = Medical Journal 2009;(1):112–4. (In Russ.)].
(check this in PDF content)
5
Bobustuc G.C., Baker C.H., Limaye A. et al. Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide. Neurooncology 2010; 12(9):917–27.
(check this in PDF content)
6
Kokunai T., Iguchi H., Tamaki N. Differentiation and growth inhibition of glioma cells induced by transfer of trk A proto-oncogene. J Neurooncol 1999;42(1): 23–34.
(check this in PDF content)
7
Борисов К.Е., Сакаева Д.Д. Таргетная терапия злокачественных глиом: состояние проблемы. Российский онкологический журнал 2011;(3):47–53. [Bоrisоv К.Е., Sаkаеvа D.D. Targeted therapy of malignant gliomas: state of the problem. Rossiyskiy onkologicheskiy zhurnal = Russian Oncological Journal 2011;(3):47–53. (In Russ.)].
(check this in PDF content)
8
Церковский Д.А. Соно-фотодинамическая терапия – новый метод лечения злокачественных опухолей мозга. Онкологический журнал 2015;9(1):94–106. [Tserkovskiy D.А. Sono-photodymanic therapy – a new method in the treatment of maligant brain tumors. Onkologicheskiy zhurnal = Oncological Journal 2015;9(1):94–106. (In Russ.)].
(check this in PDF content)
9
Pimentel E. Handbook of growth factors. In 3 vol. London, Tokyo: CRC Press Inc, 1994. Vol. 2, Ch. 5: Neurotrophic growth factors. Pр. 217–40.
(check this in PDF content)
10
Калюнов В.Н. Биология фактора роста нервной ткани. Минск: Наука и техника, 1986. 206 с. [Каlyunоv V.N. Biоlоgy of the growth factor of nervous tissue. Мinsk: Nauka i tekhnika, 1986. 206 p. (In Russ.)].
(check this in PDF content)
11
Tacconelli A., Farina A.R., Cappabianca L. et al. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 2004;6(4):347–60.
(check this in PDF content)
12
Чернов А.Н., Талабаев М.В., Конопля Н.Е. и др. Влияние химиопрепаратов и фактора роста нервов на выживаемость клеток первичной культуры нейроэпителиальных опухолей. Вестник Национальной академии наук Беларуси. Серия медицинских наук 2013;(1):46–51. [Chernov А.N., Таlаbаеv М.V., Коnоplya N.Е. et al. Action of the nerve growth factor and chemotherapeutical drugs upon the viability of the cells of the neuroepithelial tumor primary culture. Vestnik Natsional’noy akademii nauk Belarusi. Seriya meditsinskikh nauk = Proceedings of the National Academy of Sciences of Bеlarus. Series of Medical Sciences 2013;(1):46–51. (In Russ.)].
(check this in PDF content)
13
Чу Э., де Вита В. мл. Химиотерапия злокачественных опухолей. М.: Практика, 2008. 447 с. [Chu E., dе Vitа V. Jr. Chemotherapy of malignant tumors. Мoscow: Praktika, 2008. 447 p. (In Russ.)].
(check this in PDF content)
14
Wolff J.E., Kortmann R.-D., Wolff B. et al. High-dose methotrexate for pediatric high grade glioma – results of the HIT-GBM-D pilot study. J Neuroоncol 2011;102(3):433–42.
(check this in PDF content)
15
Korade M.Z., Yan C., Portugal C. et al. Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain. Neurobiol Aging 2007;28(10):1522–31.
(check this in PDF content)
16
Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Let 2001;169(2):107–14.
(check this in PDF content)
17
Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat Rev 2003;3(3):203–15.
(check this in PDF content)
18
Brodeur G.M., Nakagawara A., Yamashiro D.J. et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neuroоncol
(check this in PDF content)
19
7;31(1):249–56. 19. Harel L., Costa B., Fainzilber M. On the death Trk. Dev Neurobiol 2010;70(5):298–303.
(check this in PDF content)
20
Божкова В.П., Вепринцев Б.П., Викторов И.В. и др. Руководство по культивированию нервной ткани. Методы. Техника. Проблемы. М.: Наука, 1988. 318 c. [Bоzhkоvа V.P., Vеprintsеv B.P., Viktоrоv I.V. et al. Guidance for cultivation of nervous tissue. Меthоds. Technics. Prоblems. Мoscow: Nauka, 1988. 318 p. (In Russ.)].
(check this in PDF content)
21
Freshney R.I. Animal Cell Culture: a Practical Approach. Eds. by: W. Masters 3rd. London: Oxford University Press, 2000. 315 p.
(check this in PDF content)
22
Миронов А.Н., Бабаян Н.Д., Васильева A.Н. и др. Руководство по проведению доклинических испытаний лекарственных средств. Ч. 1. М.: Гриф и К, 2012. 944 с. [Мirоnоv А.N., Babayan N.D., Vasil’eva A.N. et al. Guidance for the testing of pre-clinical investigation of medicinal drugs. P. 1. Мoscow: Grif i К, 2012. 944 p. (In Russ.)].
(check this in PDF content)
23
Ghinelli E., Johansson J., Rios J.D. et al. Presence and localization of neurotrophins and neurotrophin receptors in rat lacrimal gland. Inv Ophthalmol Visual Sci 2003;44(8):3352–7.
(check this in PDF content)
24
Belle G., Fisher L.D., Heagerty P.J. et al. Biostatistics: a methodology for the health sciences. Canada: Jonh Wiley and Sons Inc, 2004. 889 p.
(check this in PDF content)
25
Гланц С. Медицинская и биологическая статистика. М.: Практика, 1999. 356 с. [Glаnts S. Medical and biological statistics. Мoscow: Praktika, 1999. 356 p. (In Russ.)].
(check this in PDF content)
26
Krűttgen A., Schneider I., Weis J. The dark side of the NGF family: neurotrophins in neoplasias. Brain Pathol 2006;16(4):304–10.
(check this in PDF content)
27
Chen J., Zhe X. Cotransfection of TrkA and p75NTR in neuroblastoma cell line IMR-32 promotes differentiation and apoptosis of tumor cells. Chinease Med J 2003;116(6):906–12.
(check this in PDF content)
28
Evangelopoulos M.E., Weis J., Krűttgen A. Neurotrophin effects on neuroblastoma cells: correlation with Trk and p75NTR expression and influence of TrkA receptor bodies. J Neuroоncol 2004;66(1–2):101–10.
(check this in PDF content)
29
Heymach J.V., Schooter E.M. The biosyntesis of neurotrophin heterodimeres by transfected mammalian cells. J Biol Chem 1995;270(20):12297–304.
(check this in PDF content)
30
Pflug B.R., Colangelo A.M., Tornatore C. et al. TrkA induces differentiation but not apoptosis in C6–2B glioma cells. J Neurosci Res 2001;64(6):636–45.
(check this in PDF content)
31
Wadhwa S., Nag T.C., Jindal A. et al. Expression of the neurotrophin receptors TrkA and TrkB in adult human astrocytoma and glioblastoma. J Biosci 2003;28(2): 181–8.
(check this in PDF content)